Browse products

Distribution on the pharmaceutical market in Russia and Ukraine 2011

Distribution on the pharmaceutical market in Russia and Ukraine 2011

October 2011
Pages: 135
Delivery: PDF


Our clients say... 
We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis. General Manager, Sanofi-Synthelabo
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley
Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. General Manager, Sanofi-Synthelabo
It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw

The report contains detailed characteristics of distribution on the pharmaceutical market in Russia and Ukraine. We have analysed four main segments within distribution in each country: pharmacy distribution, wholesale distribution, online sales and non-pharmacy sales. The description includes main features of the segment, profiles of largest players, and the most important legal regulations affecting the segment. Comparative analyses of individual segments in particular countries have also been presented.

Key topics discussed

Did you know... 
The number of pharmaceutical wholesalers has been falling for the past decade in Ukraine.
65% of pharmacies are situated in urban areas in Russia.
Russia's pharmaceutical retail market is relatively scattered.
Most pharmaceutical wholesalers are registered in the city of Kiev.
There are three kinds of pharmacy entity in Russia: the pharmacy, the drugstore (pharmacy point) and the pharmacy kiosk.
  • Number of pharmacy outlets in individual countries
  • Number of pharmacy outlets owned by pharmacy chains in individual countries
  • Profiles of the largest pharmacy chains in individual countries
  • Comparative analysis of pharmacy distribution in individual countries: number of pharmacies, ratio of population to number of pharmacies
  • Number of wholesalers in individual countries
  • Profiles of the largest pharmaceutical wholesalers in individual countries
  • Number of wholesale warehouses per pharmacy in individual countries
  • Comparative analysis of wholesale distribution in individual countries: number of warehouses, concentration of market players
  • Regulations regarding non-pharmacy sales of medicines in individual countries
  • Regulations regarding mail-order sales of medicines in individual countries

Report's strengths

  • complex analysis of distribution on the pharmaceutical market
  • four key segments covered
  • profiles of the largest players and informaion on their financial performance

The report answers the following questions

  • What is the ratio of population to number of pharmacies?
  • Which countries are to take initiatives to stop the number of pharmacies from increasing?
  • What trends and events have been the most important for distribution in countries analysed?
  • What expected trends and events are the most important for distribution in countries analysed?
  • In which CE country does the wholesale distribution segment demonstrate the highest degree of concentration?

...and many more!

When will the report prove useful?

  • Anyone operating on the Russian or Ukrainian pharmaceutical market
  • Anyone considering entering those pharmaceutical markets
  • Anyone planning their corporate strategy
  • Anyone analysing market competition
  • Anyone investigating Russian and Ukrainian market’s investment potential
  • Anyone gauging theopportunities for acquisition on the Russian and Ukrainian market

Who is this report for?

  • Pharma companies
  • Logistics firms
  • Pharmacy chains – domestic and foreign
  • Pharmaceutical distributors (wholesalers) – domestic and foreign
  • Foreign firms investing in the Russian and Ukrainian pharmaceutical sector
  • Consulting, research and analysis firms
  • Government institutions, embassies
  • Chambers of commerce, industry bodies
  • Universities, academic institutions
  • Financial institutions (banks, brokerage houses, investment funds)

Companies mentioned in this report:

Protek CV, Katren, SIA International, Rosta, Alliance Healthcare., A5, Apteki 36,6, Implozia, Rigla, Raduga, Pharmacor, Pharmaimpex, Starij Lekar, BaDM, Optima-Pharm, Alba Ukraine, VVS, Fra-M., Pharmacia (Lugansk), Med-Service, Poltavapharm, Pharmacia Kiev, Ukrainian Pharmacy Holding, Falbi, Arnika, Pharmastor.

Extract from this report

  • The maximum retail markup on drugs on the national list of essential drugs and medical products is 25% (10% on drugs purchased in full or in part through budgetary funds) in Ukraine.
  • The number of pharmacy outlets in Ukraine fluctuated during the past decade and stood at 22,072 in June 2011. This included 13,655 pharmacies, 5,420 drugstores and 2,997 pharmacy kiosks.
  • Retail trading in medicines in Russia may be carried out only by healthcare entities licensed for pharmaceutical activity, along with their separate subdivisions (outpatient clinics, obstetrics stations, general medical centres) located in rural areas in which there are no pharmacy outlets. 

Market commentary by expert

Russia and Ukraine are extremely attractive markets for pharmaceutical companies due to their large populations, low saturation of the market, its rapid development, and widespread unhealthy lifestyles that lead to high incidence of various diseases. The markets are also quite difficult, as legislation is vague and business climate unique. Our report will help companies wanting to invest in the region, as well as those already operating on the market, to understand and plan strategies for selling their products in Russia and Ukraine.

Monika Stefanczyk, Head Pharmaceutical Analyst

Request sample pages/interactive screenshare

To receive more information on this report, please sign up.

*required

*Would you like a FREE
interactive screenshare?
*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:

Privacy Policy

  1. Report methodology p. 7

  2. Executive summary p. 11

  3. Main trends and events in distribution, 2009-2013 p. 15

    • Main current trends 2009-2011 p. 15
      • Russia p. 15
      • Ukraine p. 21
    • Main anticipated trends p. 25
      • Russia p. 25
      • Ukraine p. 27
  4. Wholesale distribution p. 29

    • Russia p. 29
      • Number of pharmaceutical wholesalers p. 29
      • Legal regulations p. 32
      • Largest market players p. 35
        • Protek CV p. 39
        • SIA International p. 44
        • Katren ZAO p. 45
        • Rosta p. 47
        • Alliance Healthcare p. 48
    • Ukraine p. 49
      • Number of pharmaceutical wholesalers p. 49
      • Legal regulations p. 51
      • Largest market players p. 53
        • BaDM p. 55
        • Optima-Pharm p. 56
        • Alba Ukraine p. 57
        • VVS p. 58
        • Fra-M p. 59
        • Venta p. 61
    • Comparative analysis of wholesale distribution in Russia and Ukraine p. 63
      • Number of pharmaceutical wholesalers p. 63
      • Number of pharmacies per wholesaler p. 63
      • Concentration of market players p. 64
  5. Pharmacy distribution p. 65

    • Russia p. 65
      • Number of pharmacies p. 65
      • Number of people per pharmacy p. 67
      • Share of private and public pharmacies p. 69
      • Market concentration p. 70
      • Financial situation p. 73
      • Pharmacy chains p. 75
      • Market entry barriers p. 76
      • Legal regulations p. 77
      • Largest market players p. 79
        • Apteki 36,6 p. 82
        • Rigla p. 84
        • A5 p. 87
        • Pharmakor p. 90
        • Implozia p. 91
        • Pharmaimpex p. 92
        • Raduga p. 93
        • Doctor Stoletov p. 94
    • Ukraine p. 96
      • Sales by category of pharmaceutical outlet p. 96
      • Number of pharmacies p. 97
      • Legal regulations p. 102
      • Largest market players p. 104
        • Pharmacia (Lugansk) p. 108
        • Med-Service p. 109
        • Pharmacia Kiev p. 111
        • Arnika p. 112
        • Apteka Dobrogo Dnya (Pharmastor) p. 113
        • Ukrainian Pharmacy Holding p. 113
    • Comparative analysis of pharmacy distribution in Russia and Ukraine p. 114
      • Number of pharmacy outlets p. 114
      • Largest market players p. 115
  6. Non-pharmacy distribution p. 117

    • Russia p. 117
      • Legal regulations p. 117
      • Public discussion of medicines sale at non-specialist stores p. 118
    • Ukraine p. 119
      • Legal regulations p. 119
      • Public discussion of medicines sale at non-specialist stores p. 119
    • Comparative analysis of non-pharmacy distribution in Russia and Ukraine p. 120
  7. Online distribution p. 121

    • Russia p. 121
      • Legal regulations p. 121
      • Number of online pharmacies and largest online pharmacies p. 122
      • Consumer behaviour p. 123
    • Ukraine p. 123
      • Legal regulations p. 123
      • Number of online pharmacies and largest online pharmacies p. 124
    • Comparative analysis of online distribution in Russia and Ukraine p. 125
  8. List of graphs p. 127

  9. List of tables p. 131

  10. About PMR p. 133

  11. Contact PMR p. 134

List of graphs

  1. Number of medicine wholesale trade licence holders in Russia, 2004-2005 and 2009-2010       30
  2. Percentage of retail distributors cooperating with specific numbers of wholesalers in Russia, 2007-2009       30
  3. Total warehouse areas of selected pharmaceutical wholesalers in Russia (m2), August 2011       31
  4. Y-o-y change in gross and direct sales of pharmaceuticals and parapharmaceuticals by distributors in Russia (%), in euro and rouble terms, 2010        32
  5. Y-o-y change in gross and direct sales of pharmaceuticals and parapharmaceuticals by distributors in Russia (%), in euro and rouble terms Q1 2011        32
  6. Share of product groups in the sales value of pharmaceutical distributors in Russia, by category of wholesaler, 2010       34
  7. Share of different products in the sales value of pharmaceutical distributors in Russia, by category of wholesaler, Q1 2011       35
  8. Market share of the largest players on the pharmaceutical wholesale market in Russia (%), 2010       35
  9. Market share of the largest players on the pharmaceutical wholesale market in Russia (%), by direct sales, H1 2011       36
  10. Concentration of pharmaceutical wholesale market in Russia, 2006-2010       36
  11. Ten most influential pharmaceutical distributors in Russia (number of points), 2010       38
  12. Protek CV sales revenues (RUB bn) and y-o-y change in Russia, 2008-H1 2011       40
  13. Protek CV gross profit (RUB bn) and y-o-y change in Russia, 2009-H1 2011       40
  14. Breakdown of Protek CV revenues in Russia, by market subdivisions, 2008-2010       41
  15. Breakdown of Protek CV’s gross profit in Russia, by product groups, 2010       41
  16. Breakdown of Protek CV sales in Russia, by product lines, 2010       42
  17. Breakdown of Protek CV revenues in Russia, by key client groups, 2010       42
  18. SIA International sales revenues (RUB bn) and y-o-y change in Russia, 2007-2010       44
  19. Katren revenues and gross profit (RUB bn) in Russia, 2009-2010       46
  20. Breakdown of Katren revenues in Russia, by category of activity, 2010       46
  21. Rosta sales revenues (RUB bn) and y-o-y change in Russia, 2007-2010       47
  22. Alliance Healthcare sales revenues (RUB bn) and y-o-y change in Russia, 2007-2011       49
  23. Number of pharmaceutical wholesale licence holders in Ukraine, 2002-June 2011       50
  24. Location of pharmaceutical wholesale licence holders in Ukraine, by region, June 2011       50
  25. Location of pharmaceutical wholesalers’ warehouses in Ukraine, by region, June 2011       51
  26. Market shares of the largest players on the pharmaceutical wholesale market in Ukraine, 2010       53
  27. Market share of the largest three, 10 and 20 players on the pharmaceutical wholesale market in Ukraine, H1 2009-H1 2011       53
  28. Top 10 companies which won tenders conducted by the Ministry of Health in Ukraine, by value, 2010       54
  29. Top 10 companies which won tenders conducted by medical institutions in Ukraine, by value, 2010       54
  30. BaDM sales revenues (UAH bn) and y-o-y change in Ukraine, 2009-2010       55
  31. Optima-Pharm sales revenues (UAH bn) and y-o-y change in Ukraine, 2009-2010       56
  32. Alba Ukraine sales revenues (UAH bn) and y-o-y change in Ukraine, 2009-2010       57
  33. VVS sales (UAH bn) and y-o-y change in Ukraine, 2009-2010       59
  34. Fra-M sales (UAH bn) and y-o-y change in Ukraine, 2009-2010       60
  35. Venta sales (UAH bn) and y-o-y change in Ukraine, 2009-2010       61
  36. Share of product categories in Venta’s portfolio in Ukraine, 2010       62
  37. Share of OTC products in Venta sales in Ukraine, by value and volume, 2010       62
  38. Number of pharmaceutical wholesalers in Russia and Ukraine, 2010       63
  39. Number of pharmacy outlets per one pharmaceutical wholesaler in Russia and Ukraine, 2010       63
  40. Number of pharmacies and pharmacy points in Russia (‘000), 2003-March 2011       65
  41. Number of pharmacies in Russia, by location, March 2011       66
  42. Average number of enterprises running pharmacies in Russia in specific locations, 2007-2009       66
  43. Urban and municipal districts in Russia with specified number of enterprises running pharmacies (%), 2009       67
  44. Regions in Russia with the lowest density of pharmacies (by number of  people per one pharmacy), 2009       68
  45. Share of private and state/municipally-owned pharmacies as a proportion of the total number of pharmacies in Russia, 2001-2009       68
  46. Share of urban and municipal districts by levels of market concentration in Russia, 2009       71
  47. Level of pharmacy market concentration in Russia, by specific locations, 2009       72
  48. Shares of pharmacies as a proportion of total revenue and total number of pharmacies in selected regions in Russia, 2009       74
  49. Share of different products as a proportion of the sales value of  pharmacy chains in Russia, by category of pharmacy chain, 2010       74
  50. Number of pharmacy chains and groups operating in selected regions in Russia, 2004-2005 and 2007-2009       75
  51. Main market entry barriers to the retail trade in medicines and medical devices in Russia, 2011       76
  52. Selected largest pharmacy chains in Russia, by number of outlets, August 2011       79
  53. Market share of selected largest pharmacy chains in Russia, by sales value, 2009-2010        80
  54. Market share of selected largest pharmacy chains in Russia, by sales value, H1 2011       80
  55. Ten leading national and interregional pharmacy chains in Russia (by number of points), 2010       81
  56. Five leading regional pharmacy chains in Russia (by number of points), 2010       81
  57. 36,6 pharmacy chain expansion in Russia (number of units) and y-o-y change, 2003-H1 2011       82
  58. 36,6 sales revenues (RUB bn) and y-o-y change in Russia, 2004-H1 2011       83
  59. Apteki 36,6 EBITDA from retail activity (RUB bn) and y-o-y change in Russia, 2008-Q1 2011       83
  60. Rigla sales revenues (RUB bn) and y-o-y change in Russia, 2006-H1 2011       85
  61. Rigla gross profit (RUB bn) and y-o-y change in Russia, 2009-H1 2011       85
  62. Breakdown of Rigla revenues in Russia, by product groups, 2010       86
  63. A5 net revenues (RUB bn) and y-o-y change in Russia, 2007-2014       88
  64. A5 gross profit (RUB bn) and y-o-y change in Russia, 2007-2010       89
  65. Pharmakor turnover (RUB bn) and y-o-y change in Russia, 2009-2010       90
  66. Implozia turnover (RUB bn) and y-o-y change in Russia, 2009-2010       91
  67. Pharmaimpex sales revenues (RUB bn) and y-o-y change in Russia, 2008-2010       92
  68. Pharmaimpex Group profit/loss in Russia (RUB), 2008-2010       93
  69. Raduga turnover (RUB bn) and y-o-y change in Russia, 2009-2010       94
  70. Doctor Stoletov retail sales revenue (RUB bn) and y-o-y change in Russia, 2008-2010       95
  71. Share of pharmaceutical outlets as a proportion of total pharmaceutical sales value in Ukraine (%), 2010        96
  72. Average revenues per one pharmaceutical outlet in Ukraine (UAH), by category, 2010       96
  73. Total number of pharmaceutical outlets in Ukraine, January 2002-June 2011       97
  74. Number of pharmaceutical outlets in Ukraine, by category, June 2011       97
  75. Number of pharmaceutical outlets in Ukraine, by category, January 2002-June 2011       98
  76. Breakdown of the pharmacy market in terms of different kinds of outlets in Ukraine, by number of outlets, 2009-2011       98
  77. Number of pharmaceutical outlets in Ukraine, by category of outlet and location, June 2011       99
  78. Top 10 regions with majority of pharmacy kiosks in urban areas of Ukraine, March 2011       100
  79. Population per one pharmaceutical outlet in urban areas in Ukraine, by regions, March 2011       101
  80. The number of people for every pharmaceutical outlet in rural areas of Ukraine, by regions, March 2011       102
  81. Selected largest pharmacy chains in Ukraine, by number of outlets, August 2011       104
  82. Concentration of pharmacy chains in Ukraine and in specific regions, market share by sales value, 2010       105
  83. Market share of selected largest pharmacy chains in Ukraine, by sales value, Q1-Q3 2010       105
  84. Sales revenues of selected largest pharmacy chains in Ukraine (UAH m), Q1-Q3 2010       106
  85. Share of pharmaceutical outlets in Ukraine, by the size of the pharmaceutical company, 2009-2011       106
  86. Percentage of pharmaceutical companies of different sizes in Ukraine, by category of town, 1 January 2011       107
  87. Proportion of pharmaceutical outlets owned by private entrepreneurs in Ukraine (%), 2006-2011       107
  88. Pharmacia Lugansk sales revenues (UAH m) and y-o-y change in Ukraine, 2006-2009       108
  89. Med-Service sales in Ukraine, by regions (%), 2010       110
  90. Pharmacia Kiev sales revenues (UAH m) and y-o-y change in Ukraine, 2006-2009       111
  91. Arnika sales revenues (UAH m) and y-o-y change in Ukraine, 2006-2009       112
  92. Number of pharmacy outlets in Russia and Ukraine, 2011       114
  93. Mean population to pharmacy ratio in Russia and Ukraine, 2011       115
  94. Comparison of non-pharmacy sales of medicines in Russia and Ukraine, 2011       120
  95. Comparison of online sales of medicines in Russia and Ukraine, 2011       125

List of tables

  1. Top five pharmaceutical distributors by breakdown of gross sales to Russia’s Federal districts, Q1 2011 37
  2. Leading pharmaceutical wholesale distributors on regional markets in Russia, market share by sales value, 2009 39
  3. Basic information on Protek CV pharmaceutical wholesale activity in Russia, 2011 39
  4. Basic details on Protek’s warehouses in Russia, 2008-2010 44
  5. Basic information on SIA International pharmaceutical wholesale activity in Russia, 2011 45
  6. Basic information on Katren ZAO pharmaceutical wholesale activity in Russia, 2011 47
  7. Basic information on Rosta pharmaceutical wholesale activity in Russia, 2011 48
  8. Basic information on Alliance Healthcare Russia pharmaceutical wholesale activity in Russia, 2011 55
  9. Basic information on BaDM pharmaceutical wholesale activity in Ukraine, 2011 56
  10. Basic information on Optima-Pharm pharmaceutical wholesale activity in Ukraine, 2011 57
  11. Basic information on Alba Ukraine pharmaceutical wholesale activity in Ukraine, 2011 58
  12. Basic information on VVS pharmaceutical wholesale activity in Ukraine, 2011 59
  13. Basic information on Fra-M pharmaceutical wholesale activity in Ukraine, 2011 60
  14. Basic information on Venta pharmaceutical wholesale activity in Ukraine, 2011 61
  15. Market shares of leading players and five largest wholesalers in Russia and Ukraine, 2010 64
  16. Regions with the highest proportion of privately-owned pharmacies in Russia, 2009 69
  17. Regions with the highest percentages of state or municipally-owned pharmacies in Russia, 2009 70
  18. Urban and municipal districts with the lowest level of pharmacy concentration in Russia, 2009 72
  19. Urban and municipal districts with the highest level of pharmacy concentration in Russia, 2009 73
  20. Number of pharmacy outlets operated by A5 in Russia, by location, August 2011 88
  21. Number of pharmacy outlets operated by Pharmaimpex in Russia, by location, August 2011 92
  22. Number of pharmacy outlets operated by Doctor Stoletov in Russia, by location, August 2011 94
  23. Number of pharmacy outlets operated by Pharmacia (Lugansk) in Ukraine, by location, August 2011 108
  24. Number of pharmacy outlets operated by Med-Service in Ukraine, by location, August 2011 109
  25. Number of pharmacy outlets operated by Arnika in Ukraine, by location, August 2011 112
  26. Top 10 pharmacy chains in Russia and Ukraine, by number of outlets, 2011 115
Distribution on the pharmaceutical market in Russia and Ukraine 2011

Choose your version of this product:

Select
language:
Select
licence:
     Price: 1500
Language / Licence Single 5 Users Corporate Global
English1500225030003750

Compare licences
  • "Single user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of one computer belonging to the client;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "5-user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Corporate licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Global licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
    PMR is a member of SIIA's Corporate Content Anti-Piracy Program. Breaking the conditions of our licences will result in a report being sent to SIIA to initiate a piracy investigation and major fees may be imposed by the SIIA as a result. Additionally, for newsletters and online services, it will result in suspension of the subscription with no money refund.